Product Information for the Patient
Paliperidone TAD3 mg prolonged-release tablets EFG
Paliperidone TAD6 mg prolonged-release tablets EFG
Paliperidone TAD9 mg prolonged-release tablets EFG
Read this entire leaflet carefully before you start taking this medicine because it contains important information for you.
-Keep this leaflet, as you may need to read it again.
-If you have any questions, ask your doctor or pharmacist.
-This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.
1.What Paliperidone TAD is and what it is used for
2.What you need to know before taking Paliperidone TAD
3.How to take Paliperidone TAD
4.Possible side effects
5.Storage of Paliperidone TAD
6.Contents of the pack and additional information
Paliperidone contains the active ingredient paliperidone, which belongs to the class ofmedicamentosantipsicóticos.
Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms that include hearing, seeing or feeling things thatdonotexist, holding false beliefs, having an abnormal distrust, becoming withdrawn, speaking incoherently and flattening of behavior and emotion. People with this disorder may also feel depressed, anxious, guilty ortense.
Paliperidone is also used to treat schizoaffective disorder inadultos.
Schizoaffective disorder is a mental condition in which the person experiences several of the symptoms of schizophrenia (listed in the previous paragraph) in addition to symptoms of mood disorder (feeling of euphoria, sadness, agitation, being distracted, insomnia, loquacity, loss of interest in daily activities, excessive or inadequate sleep, excessive or inadequate food intake, and recurring thoughts ofsuicidio).
Paliperidone may help alleviate the symptoms of your illness and prevent it fromreaparezcan.
Do not takepaliperidone
-if you are allergic to paliperidone, risperidone, or any of the other ingredients in thismedicine(listed in section6)
Warnings andprecautions
Consult your doctor or pharmacist before starting to take paliperidone..
If you have any of these conditions, please consult your doctor as it may benecessaryor a dose adjustment or monitoring for atimepoderioduringaperiod.
Because in very rare cases, apeligrosallylowwhitebloodcellsnecessarytocombatetheirnumberofcells.
Paliperidone may cause you to gain weight. Significant weight gain canafectarnegativelyyourhealth.
In patients treated with paliperidone, diabetes mellitus or worsening ofdiabetesmellitus preexisting has been observed, your doctor should check for signs of increased blood sugar.Inpacientswithdiabetesmellitus preexisting should be regularly monitored for blood sugar.
During cataract surgery, the pupil (thenegrospartoftheeyeye) may not dilate as needed. Additionally, the iris (thepartcoloredpartoftheeyeyeyeyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyy Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Use in adults The recommended dose in adults is 6 mg once a day in the morning. Your doctor may increase or decrease it within the dosing interval of 3 mg to 12 mg once a day in case of schizophrenia or 6 mg to 12 mg once a day in case of schizoaffective disorder. This depends on how well the medication works for you. Use in adolescents and children The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years or older is 3 mg once a day taken in the morning. For adolescents weighing 51 kg or more, the dose can be increased within the interval of 6 mg to 12 mg once a day. For adolescents weighing less than 51 kg, the dose can be increased to 6 mg once a day. Your doctor will decide how much to administer to you. The amount you take depends on how well the medication works for you. How and when to take paliperidone This medication should be taken by mouth, swallowed whole with water or other liquids. It should not be chewed, broken, or crushed. This medication should be taken in the mornings with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication with breakfast and on an empty stomach the next day. The active ingredient, paliperidone, dissolves once swallowed, and the coating of the tablet is eliminated from the body by the kidneys. Patients with kidney problems Your doctor may adjust the dose of this medication according to your kidney function. Patients of advanced age Your doctor may reduce your medication dose if your kidney function is reduced. If you take more paliperidone than you should In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicological Information Service. Phone: 91 562 04 20 indicating the medication and the amount ingested. You may experience drowsiness, confusion, abnormal body movements, difficulty staying upright and walking, dizziness due to reduced blood pressure, and alterations in heartbeats. If you forgot to take paliperidone Do not take a double dose to compensate for the missed doses. If you forget a dose, take the next dose the next day. If you forget two or more doses, contact your doctor. If you interrupt the treatment with paliperidone Do not stop taking this medication as you will lose the effects of the medication. Do not stop taking this medication unless your doctor tells you to, as the symptoms may reappear. If you have any other doubts about the use of this medication, ask your doctor or nurse. Like all medicines, this medicine can cause side effects, althoughnotall people experience them. Inform your doctor immediately if you experience any of the following: Very common side effects: can affect more than 1 in 10 patients Common side effects: can affect up to 1 in 10 patients Rare side effects: can affect up to 1 in 1,000 patients Unknown: their frequency cannot be estimated from the available data The following side effects have appeared with the use of another medication called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone: eating disorder related to sleep, other types of blood vessel problems in the brain, crackling sounds from the lungs, and severe or life-threatening skin rash with blisters and peeling of the skin that can start in the mouth, nose, eyes, and genitals and spread to other parts of the body (Stevens-Johnson syndrome/toxic epidermal necrolysis). Other eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken this medication. Additional side effects in adolescents Adolescents generally experienced side effects similar to those found in adults, except for the following side effects that were detected more frequently: Reporting of side effects If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication. Keep this medication out of the sight and reach of children. Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated. Store in the original packaging to protect it from moisture. This medication does not require any special storage temperature. Do not dispose of medications through drains or trash. Deposit empty containers and unused medications at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of empty containers and unused medications. This will help protect the environment. Paliperidone TAD Composition - The other components are: Core: macrogol 200 000, macrogol 7 000 000, macrogol 4000, hydroxybutyltoluene, povidone, sodium chloride, microcrystalline cellulose, magnesium stearate, red iron oxide (E172), hydroxypropylcellulose, and cellulose acetate. Covering: hypromellose, titanium dioxide (E171), talc, propylene glycol, yellow iron oxide (E172) – only for 6 mg tablets, and red iron oxide (E172) – only for 9 mg tablets. Printed ink: shellac, black iron oxide (E172), and propylene glycol. See section 2 “Paliperidone TAD contains sodium”. Appearance of the product and contents of the package 3 mg: Coated tablets with a film, biconvex, round, white to grayish white in color, with a possible irregular surface, and printed with the mark P3 on one side of the tablet. Diameter: approximately 9 mm. 6 mg: Coated tablets with a film, biconvex, round, yellowish brown in color, with a possible irregular surface, and printed with the mark P6 on one side of the tablet. Diameter: approximately 9 mm. 9 mg: Coated tablets with a film, biconvex, round, light pink in color, with a possible irregular surface, and printed with the mark P9 on one side of the tablet. Diameter: approximately 9 mm. Paliperidone TAD are available in packages of 14x1, 28x1, and 56x1 prolonged-release tablets in blister packs. Only some package sizes may be marketed. Marketing Authorization Holder TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany Responsible for manufacturing KRKA d.d. Novo mesto, Smarjeska cesta 6, 8501 Novo mesto, Slovenia You can request more information about this medicine by contacting the local representative of the marketing authorization holder: KRKA Farmacéutica, S.L., C/ Anabel Segura 10, 28108 Alcobendas, Madrid, Spain This medicine is authorized in the member states of the European Economic Area with the following names: Member state name Medicine name Hungary Paliperidon Krka 3 mg retard tabletta Paliperidon Krka 6 mg retard tabletta Paliperidon Krka 9 mg retard tabletta Belgium Paliperidon Krka 3 mg tabletten met verlengde afgifte Paliperidon Krka 6 mg tabletten met verlengde afgifte Paliperidon Krka 9 mg tabletten met verlengde afgifte Cyprus Paliperidon TAD Denmark Paliperidon Krka Spain Paliperidona TAD 3 mg prolonged-release tablets EFG Paliperidona TAD 6 mg prolonged-release tablets EFG Paliperidona TAD 9 mg prolonged-release tablets EFG Iceland Paliperidon Krka 3 mg forðatöflur Paliperidon Krka 6 mg forðatöflur Paliperidon Krka 9 mg forðatöflur Italy Paliperidone Krka Ireland Paliperidon TAD Sweden Paliperidon Krka 3 mg depottabletter Paliperidon Krka 6 mg depottabletter Paliperidon Krka 9 mg depottabletter Last review date of this leaflet: April 2024 The detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/ 3. How to Take Paliperidone TAD
4. Possible Adverse Effects
5. Paliperidone TAD Storage
6. Contents of the packaging and additional information
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.